FTRE

Fortrea Holdings Inc. (FTRE) | Rumor.io

Fortrea Holdings

FTRE

Attention (50-day avg)0%

Attention rank (50-day avg)#3,179

Bullish sentiment (50-day avg)100%

Price to earnings ratio522.3

Market capitalization1.9B

Earnings per share-0.83

Dividend yield (TTM)—

Revenue (annual)2.7B

Net income (annual)-986.2M

Social

What share of all stock conversation is about FTRE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

May 5

Fortrea Holdings Inc. ($FTRE) reported Q1 2026 revenue of $636.5M, down from $651.3M a year ago, with adjusted net income of $15.2M vs GAAP loss of $23.6M.
The company maintained its full-year revenue guidance of $2.55B-$2.65B and launched a new product, with a strong backlog of $7.8B and a book-to-bill ratio of 1.15x.
Fortrea's adjusted EBITDA surged 55% YoY to $47.0 million, expanding margins, while the company's commercial momentum and operational improvements were highlighted during the Q1 2026 earnings call.

Generated by AI

Sentiment

Of the messages about FTRE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	90.38% +25.86
Bearish	—	—	0% 0	9.62% -25.86

Nov 8

Fortrea Holdings Inc.'s ($FTRE) stock has shown significant growth, increasing by 32.33% after its announcement in the biotech sector.
The company's clinical development services and innovative therapies have the potential to drive further growth, as evidenced by its leading position in the global CRO market.
Fortrea's insider buying activity suggests confidence in the company's future prospects, with insiders purchasing shares at a price of $25.30, indicating a belief in the stock's potential for long-term gains.

Generated by AI

Topics

Of the messages about FTRE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	100%	98%	51.69%
Announcements	—	0%	2%	32.85%
Analysts	—	0%	0%	13.04%
Controversies	—	0%	0%	0%
Earnings	—	0%	0%	0.48%
Macro	—	0%	0%	1.93%

Mar 11

Fortrea Holdings Inc. (FTRE) signed a definitive agreement to divest its Endpoint Clinical and Patient Access businesses to Arsenal Capital Partners for $345 million.
FTRE reported Q4 2023 revenue of $775.4 million and a net loss of $36 million, with full-year 2024 guidance for revenue of $3.14-$3.2 billion and adjusted EBITDA of $280-$320 million.
The company plans to close the divestiture of Endpoint Clinical and Patient Access in the second quarter of 2024, refocusing on its clinical development services for phases 1-4.

Generated by AI

Community

Of the messages about FTRE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	10.71%	31.32%
Newcomers	—	100%	89.29%	68.68%

Aug 4

Newcomers to Fortrea Holdings ($FTRE) are excited about the 30% price increase since July 11th, and are wondering if the upward trend will continue.
Fortrea Holdings' stock ($FTRE) surged 17% after a bullish analyst upgrade, with Baird predicting long-term potential and a potential upside of 56.79%.
The Baird analyst's upgrade from Neutral to Outperform has sparked a short squeeze, with a short ratio over 5 indicating potential selling pressure and a strong price action confirming bullish sentiment.

Generated by AI

DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the granting of an inducement award of restricted stock units (“RSUs”) and performance share units (“PSUs”) on September 10, 2026, to five newly hired employees. Included in these awards were grants of employment inducement awards to Jason Knoblauch, the Company’s recently appointed Chief Financial Officer, as an inducement material to

19d agoYahoo Finance

Fortrea to Participate in September Investor Conferences

DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relations, Tracy Krumme will participate in the following conferences in September: Baird 2026 Global Healthcare Conference (NYC) Date: Tuesday, September 15, 2026Format: Fireside Chat & 1x1 and Group MeetingsTime: 2:00 -2:30 PM EDTWebcast: FTRE Baird Webcast Deutsche Bank 2026 Healthcar

19d agoYahoo Finance

Stocks making big moves this week: SAIC, Reddit, Fortrea, GitLab, and G-III

Check out the companies making headlines this week:

25d agoYahoo Finance

Fortrea: A Surprising M&A Move During The Recovery (NASDAQ:FTRE)

25d agoSeeking Alpha

Stocks making big moves yesterday: Limbach, FuelCell Energy, Ollie's, Fortrea, and G-III

Check out the companies making headlines yesterday:

26d agoYahoo Finance

Fortrea (FTRE) Stock Is Up, What You Need To Know

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 3% in the afternoon session after the company agreed to acquire the Early Phase Services division of Worldwide Clinical Trials.

27d agoYahoo Finance

Also Discussed

Investors talking about FTRE also mention

#	Name	Attention
1	Vestis CorporationVSTS	0%new
2	Dianthus Therapeutics Inc.DNTH	0%0
3	Integra LifeSciences Holdings CorporationIART	0%0
4	Bruker CorpBRKR	0%0
5	Insight Enterprises, Inc.NSIT	0%0
6	Acadia Healthcare Company, Inc.ACHC	0%new
7	CareDx IncCDNA	0.01%+0.01
8	UroGen Pharma Ltd.URGN	0%new
9	Forte Biosciences, Inc.FBRX	0%new
10	Travere Therapeutics Inc.TVTX	0%0

Fortrea Holdings Inc.

Healthcare
Biotechnology

Fortrea Holdings Inc. is a global contract research organization that provides clinical development solutions to pharmaceutical, biotechnology, and medical device companies. Fortrea Holdings Inc. supports clients across the full clinical trial lifecycle, including Phase I through Phase IV studies, clinical pharmacology, data management, biostatistics, regulatory support, and post-approval evidence services. The company offers flexible delivery models such as full-service, functional service provider, and hybrid arrangements to fit different development needs. Its services are used by biopharma and medtech customers seeking to manage complex trials, improve operational efficiency, and generate the clinical evidence needed to advance products through development and approval. Fortrea Holdings Inc. is headquartered in Durham, North Carolina, and operates as a specialized services provider in the life sciences market.

Website

Location

8 Moore Drive

Durham, NC, 27709

United States

Social

What share of all stock conversation is about FTRE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

May 5

Fortrea Holdings Inc. ($FTRE) reported Q1 2026 revenue of $636.5M, down from $651.3M a year ago, with adjusted net income of $15.2M vs GAAP loss of $23.6M.
The company maintained its full-year revenue guidance of $2.55B-$2.65B and launched a new product, with a strong backlog of $7.8B and a book-to-bill ratio of 1.15x.
Fortrea's adjusted EBITDA surged 55% YoY to $47.0 million, expanding margins, while the company's commercial momentum and operational improvements were highlighted during the Q1 2026 earnings call.

Generated by AI

Sentiment

Of the messages about FTRE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	90.38% +25.86
Bearish	—	—	0% 0	9.62% -25.86

Nov 8

Fortrea Holdings Inc.'s ($FTRE) stock has shown significant growth, increasing by 32.33% after its announcement in the biotech sector.
The company's clinical development services and innovative therapies have the potential to drive further growth, as evidenced by its leading position in the global CRO market.
Fortrea's insider buying activity suggests confidence in the company's future prospects, with insiders purchasing shares at a price of $25.30, indicating a belief in the stock's potential for long-term gains.

Generated by AI

Topics

Of the messages about FTRE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	100%	98%	51.69%
Announcements	—	0%	2%	32.85%
Analysts	—	0%	0%	13.04%
Controversies	—	0%	0%	0%
Earnings	—	0%	0%	0.48%
Macro	—	0%	0%	1.93%

Mar 11

Fortrea Holdings Inc. (FTRE) signed a definitive agreement to divest its Endpoint Clinical and Patient Access businesses to Arsenal Capital Partners for $345 million.
FTRE reported Q4 2023 revenue of $775.4 million and a net loss of $36 million, with full-year 2024 guidance for revenue of $3.14-$3.2 billion and adjusted EBITDA of $280-$320 million.
The company plans to close the divestiture of Endpoint Clinical and Patient Access in the second quarter of 2024, refocusing on its clinical development services for phases 1-4.

Generated by AI

Community

Of the messages about FTRE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	10.71%	31.32%
Newcomers	—	100%	89.29%	68.68%

Aug 4

Newcomers to Fortrea Holdings ($FTRE) are excited about the 30% price increase since July 11th, and are wondering if the upward trend will continue.
Fortrea Holdings' stock ($FTRE) surged 17% after a bullish analyst upgrade, with Baird predicting long-term potential and a potential upside of 56.79%.
The Baird analyst's upgrade from Neutral to Outperform has sparked a short squeeze, with a short ratio over 5 indicating potential selling pressure and a strong price action confirming bullish sentiment.

Generated by AI

Fortrea Holdings

Social

May 5

Sentiment

Nov 8

Topics

Mar 11

Community

Aug 4

News

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fortrea to Participate in September Investor Conferences

Stocks making big moves this week: SAIC, Reddit, Fortrea, GitLab, and G-III

Fortrea: A Surprising M&A Move During The Recovery (NASDAQ:FTRE)

Stocks making big moves yesterday: Limbach, FuelCell Energy, Ollie's, Fortrea, and G-III

Fortrea (FTRE) Stock Is Up, What You Need To Know

Also Discussed

Fortrea Holdings Inc.

Company Information

Location

News

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fortrea to Participate in September Investor Conferences

Stocks making big moves this week: SAIC, Reddit, Fortrea, GitLab, and G-III

Fortrea: A Surprising M&A Move During The Recovery (NASDAQ:FTRE)

Stocks making big moves yesterday: Limbach, FuelCell Energy, Ollie's, Fortrea, and G-III

Fortrea (FTRE) Stock Is Up, What You Need To Know

Also Discussed

Social

May 5

Sentiment

Nov 8

Topics

Mar 11

Community

Aug 4